There are currently 3 stickys on the board. Of the 3, 2 (PITTCON & ISOEN) are directly in regards to our POC FAIMS technology - right? The other sticky is currently our most important at this time - which is our CLINICAL TRIAL. However, you go too far IMO regarding keeping the main thing - The Main Thing.
However, when you claim the shared technology between Breathtec and Cannabix is "not advanced stage technology," you diminish the importance of our product and upcoming events IMO. I cant reason how one would attract new investors by cannibalizing shared technology? Too which, Breathtec would not exist be it not for Cannabix - it's just a fact.
Furthermore, it is not about the FAIMS per se that harnesses the intellectual prowress of our technology. It is Dr. Richard Yost (The Yost Group) and The University of Florida's "Partial Ovoidal FAIMS Electrode" that is the Golden Goose. Shell has spoken exhaustively in this regard. I may vehemently disagree at times with shell and others over facts, opinions, and/or Crystal Ball Theories, but at the end of the day, were all still here, and everybody has the right to voice their opinions. It's your opinion hoyo, I'm just directly (broke my promise) offering you mine.
Here's just one of many posts from shell regarding our shared Patent:
shell3 Friday, 12/04/15 03:01:54 PM Re: None Post # 8376 of 16553 Go